136 related articles for article (PubMed ID: 18082198)
21. Association of testis derived transcript gene variants and prostate cancer risk.
Liu X; Cicek MS; Plummer SJ; Jorgenson E; Casey G; Witte JS
J Urol; 2007 Mar; 177(3):894-8. PubMed ID: 17296370
[TBL] [Abstract][Full Text] [Related]
22. Identification and association of the single nucleotide polymorphisms, C-509T, C+466T and T+869C, of the TGF-β1 gene in patients with asthma and their influence on the mRNA expression level of TGF-β1.
Panek M; Pietras T; Fabijan A; Zioło J; Wieteska L; Małachowska B; Fendler W; Szemraj J; Kuna P
Int J Mol Med; 2014 Oct; 34(4):975-86. PubMed ID: 25119113
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor beta 1 is a novel susceptibility gene for adolescent idiopathic scoliosis.
Ryzhkov II; Borzilov EE; Churnosov MI; Ataman AV; Dedkov AA; Polonikov AV
Spine (Phila Pa 1976); 2013 May; 38(12):E699-704. PubMed ID: 23446766
[TBL] [Abstract][Full Text] [Related]
24. Association of the transforming growth factor ß1 promoter polymorphism, C-509T, with smoking status and survival in advanced non-small cell lung cancer.
Togashi Y; Masago K; Fujita S; Kim YH; Sakamori Y; Hatachi Y; Fukuhara A; Nagai H; Mio T; Mishima M
Oncol Rep; 2011 Feb; 25(2):377-82. PubMed ID: 21165571
[TBL] [Abstract][Full Text] [Related]
25. Racial differences in clinically localized prostate cancers of black and white men.
deVere White RW; Deitch AD; Jackson AG; Gandour-Edwards R; Marshalleck J; Soares SE; Toscano SN; Lunetta JM; Stewart SL
J Urol; 1998 Jun; 159(6):1979-82; discussion 1982-3. PubMed ID: 9598502
[TBL] [Abstract][Full Text] [Related]
26. Influence of TGFB1 C-509T polymorphism on gastric cancer risk associated with TGF-β1 expression in the gastric mucosa.
Choi YJ; Kim N; Shin A; Lee HS; Nam RH; Chang H; Shin CM; Park YS; Lee DH; Park JH; Jung HC
Gastric Cancer; 2015 Jul; 18(3):526-37. PubMed ID: 25118995
[TBL] [Abstract][Full Text] [Related]
27. The C-509T promoter polymorphism of the transforming growth factor beta-1 gene is associated with levels of total and specific IgE in a Colombian population.
Acevedo N; Vergara C; Gusmão L; Jiménez S; Martínez B; Mercado D; Caraballo L
Int Arch Allergy Immunol; 2010; 151(3):237-46. PubMed ID: 19786804
[TBL] [Abstract][Full Text] [Related]
28. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
29. Association of polymorphisms in TGFB1, XRCC1, XRCC3 genes and CD8 T-lymphocyte apoptosis with adverse effect of radiotherapy for prostate cancer.
Mališić E; Petrović N; Brengues M; Azria D; Matić IZ; Srbljak Ćuk I; Kopčalić K; Stanojković T; Nikitović M
Sci Rep; 2022 Dec; 12(1):21306. PubMed ID: 36494413
[TBL] [Abstract][Full Text] [Related]
30. Genetic Polymorphisms of TGFB1, TGFBR1, SNAI1 and TWIST1 Are Associated with Endometrial Cancer Susceptibility in Chinese Han Women.
Yang L; Wang YJ; Zheng LY; Jia YM; Chen YL; Chen L; Liu DG; Li XH; Guo HY; Sun YL; Tian XX; Fang WG
PLoS One; 2016; 11(5):e0155270. PubMed ID: 27171242
[TBL] [Abstract][Full Text] [Related]
31. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
32. Is there a difference in outcome after radical prostatectomy between patients with biopsy Gleason sums 4, 5, and 6? Results from the SEARCH database.
Freedland SJ; Amling CL; Terris MK; Presti JC; Aronson WJ; Elashoff D; Kane CJ;
Prostate Cancer Prostatic Dis; 2003; 6(3):261-5. PubMed ID: 12970733
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
[TBL] [Abstract][Full Text] [Related]
34. The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.
Eminaga O; Hinkelammert R; Titze U; Abbas M; Eltze E; Bettendorf O; Semjonow A
Urol Oncol; 2014 Jan; 32(1):32.e17-25. PubMed ID: 23434425
[TBL] [Abstract][Full Text] [Related]
35. A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.
Pierorazio PM; Ross AE; Schaeffer EM; Epstein JI; Han M; Walsh PC; Partin AW
J Urol; 2011 May; 185(5):1691-7. PubMed ID: 21419448
[TBL] [Abstract][Full Text] [Related]
36. Functional polymorphism in the CAV1 T29107A gene and its association with prostate cancer risk among Japanese men.
Sugie S; Tsukino H; Yamauchi T; Mukai S; Fujii M; Shibata N; Kuroda Y; Kamoto T
Anticancer Res; 2013 Mar; 33(3):1023-7. PubMed ID: 23482776
[TBL] [Abstract][Full Text] [Related]
37. c.29C>T polymorphism in the transforming growth factor-β1 (TGFB1) gene correlates with increased risk of urinary bladder cancer.
Gautam KA; Pooja S; Sankhwar SN; Sankhwar PL; Goel A; Rajender S
Cytokine; 2015 Oct; 75(2):344-8. PubMed ID: 26048435
[TBL] [Abstract][Full Text] [Related]
38. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
39. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
40. Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men.
Beuten J; Gelfond JA; Martinez-Fierro ML; Weldon KS; Crandall AC; Rojas-Martinez A; Thompson IM; Leach RJ
Carcinogenesis; 2009 Aug; 30(8):1372-9. PubMed ID: 19528667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
